» Articles » PMID: 9647380

Alendronate-associated Esophagitis: Endoscopic and Pathologic Features

Overview
Date 1998 Jul 1
PMID 9647380
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

From pill to pain: Alendronate-induced esophageal injury-A case report and review.

Fan Z, Khizar H, Lu J, Wang A, Xun T, Zhang X JGH Open. 2024; 8(6):e13080.

PMID: 38832136 PMC: 11144282. DOI: 10.1002/jgh3.13080.


Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials.

Domotor Z, Vorhendi N, Hanak L, Hegyi P, Kiss S, Csiki E Front Endocrinol (Lausanne). 2020; 11:573976.

PMID: 33240217 PMC: 7683730. DOI: 10.3389/fendo.2020.573976.


Perforation of gastric volvulus within a giant hiatus hernia secondary to alendronate: A rare complication of bisphosphonate use.

Kwan B, Wong J Int J Surg Case Rep. 2020; 73:5-8.

PMID: 32622185 PMC: 7334440. DOI: 10.1016/j.ijscr.2020.06.068.


Oral bisphosphonates and upper gastrointestinal toxicity: a study of cancer and early signals of esophageal injury.

Morden N, Munson J, Smith J, Mackenzie T, Liu S, Tosteson A Osteoporos Int. 2014; 26(2):663-72.

PMID: 25349053 PMC: 4511107. DOI: 10.1007/s00198-014-2925-9.


Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females.

Mok J, Jung C, Kim C, Ryu C, Kim Y, Kim S Korean J Intern Med. 2013; 28(6):694-700.

PMID: 24307845 PMC: 3846995. DOI: 10.3904/kjim.2013.28.6.694.